| Officer | Age | In this role | Source |
|---|---|---|---|
|
Michael Halstead
Chief Executive Officer
Title from the Form 4 dated Sep 21, 2026
|
Not stated | Not stated | |
|
Greg Cavers
Chief Financial Officer
|
56 |
Since 2020
6 years
|
|
|
Aaron Bartlone
Chief Operating Officer
|
59 |
Since 2023
3 years
|
|
|
Gabriel Fahel
Chief Legal Officer and Corporate Secretary
|
51 |
Since 2020
6 years
|
|
|
Paul Glavine
Also a director
Chief Growth Officer and Director
|
37 | Not stated | |
|
George Tziras
Chief Business Officer
|
45 |
Since 2023
3 years
|
Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.
Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.
Related-party transactions come from the company’s proxy statement. Helus Pharma Inc. has not filed one with the SEC.
Loading...